INmune Bio, Inc. (INMB) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 50K | 0 | 0 | 0 | 14K | 28K | 43K | 46K | 38K | 97K | 98K | 16K | 163K | 163K | 14K | 0 |
| Revenue Growth % | -100% | - | - | - | 257.14% | -100% | -100% | -100% | -63.16% | -71.13% | -56.12% | 187.5% | -76.69% | -40.49% | 600% | - | 3975% | 1381.82% | - | - |
| Cost of Goods Sold | 52K | 56K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -52K | -56K | 0 | 0 | 50K | 0 | 0 | 0 | 14K | 28K | 43K | 46K | 38K | 97K | 98K | 16K | 163K | 163K | 14K | 0 |
| Gross Margin % | - | - | - | - | 100% | - | - | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | - |
| Gross Profit Growth % | -204% | - | - | - | 257.14% | -100% | -100% | -100% | -63.16% | -71.13% | -56.12% | 187.5% | -76.69% | -40.49% | 600% | - | 3975% | 1381.82% | - | - |
| Operating Expenses | 5.76M | 5.42M | 7.43M | 24.57M | 9.96M | 9.47M | 12.29M | 9.87M | 11.03M | 8.41M | 8.57M | 6.46M | 6.46M | 5.74M | 7.54M | 6.4M | 6.64M | 9.19M | 9.04M | 6.55M |
| OpEx % of Revenue | - | - | - | - | 19910% | - | - | - | 78792.86% | 30025% | 19932.56% | 14036.96% | 17002.63% | 5916.49% | 7694.9% | 40025% | 4074.23% | 5639.88% | 64535.71% | - |
| Selling, General & Admin | 2.17M | 3.15M | 2.55M | 2.25M | 2.32M | 2.11M | 2.22M | 2.81M | 2.34M | 2.4M | 2.59M | 2.31M | 2.33M | 2.33M | 2.38M | 2.21M | 2.33M | 2.13M | 2.52M | 2.09M |
| SG&A % of Revenue | - | - | - | - | 4632% | - | - | - | 16700% | 8571.43% | 6013.95% | 5019.57% | 6126.32% | 2401.03% | 2430.61% | 13843.75% | 1430.67% | 1303.68% | 17964.29% | - |
| Research & Development | 3.64M | 2.33M | 4.89M | 5.8M | 7.64M | 7.35M | 10.07M | 7.05M | 8.69M | 6.01M | 5.99M | 4.15M | 4.13M | 3.41M | 5.16M | 4.19M | 4.31M | 7.07M | 6.52M | 4.46M |
| R&D % of Revenue | - | - | - | - | 15278% | - | - | - | 62092.86% | 21453.57% | 13918.6% | 9017.39% | 10876.32% | 3515.46% | 5264.29% | 26181.25% | 2643.56% | 4336.2% | 46571.43% | - |
| Other Operating Expenses | -52K | -56K | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.81M | -5.47M | -7.43M | -24.57M | -9.9M | -9.47M | -12.29M | -9.87M | -11.02M | -8.38M | -8.53M | -6.41M | -6.42M | -5.64M | -7.44M | -6.39M | -6.48M | -9.03M | -9.02M | -6.55M |
| Operating Margin % | - | - | - | - | -19810% | - | - | - | -78692.86% | -29925% | -19832.56% | -13936.96% | -16902.63% | -5816.49% | -7594.9% | -39925% | -3974.23% | -5539.88% | -64435.71% | - |
| Operating Income Growth % | 41.32% | 42.18% | 39.5% | -149.07% | 10.09% | -12.98% | -44.07% | -53.88% | -71.52% | -48.51% | -14.58% | -0.36% | 0.85% | 37.52% | 17.49% | 2.53% | -42.44% | -181.4% | -87.2% | -211% |
| EBITDA | -5.81M | -5.42M | -7.43M | -8.06M | -9.9M | -9.22M | -12.09M | 0 | -11.02M | -8.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.02M | -6.66M |
| EBITDA Margin % | - | - | - | - | -19810% | - | - | - | -78692.86% | -29925% | - | - | - | - | - | - | - | - | -64435.71% | - |
| EBITDA Growth % | 41.32% | 41.22% | 38.53% | - | 10.09% | -10.01% | - | - | - | - | - | - | - | - | 100% | 100% | - | - | -902200% | -215.73% |
| D&A (Non-Cash Add-back) | 0 | 56K | 0 | 0 | 0 | 0 | 0 | 9.87M | 0 | 0 | 8.53M | 6.41M | 6.42M | 5.64M | 7.44M | 6.39M | 6.48M | 9.03M | 0 | 0 |
| EBIT | -5.81M | -5.47M | -7.43M | -8.06M | -9.9M | -9.22M | -12.09M | -9.87M | -11.03M | -8.41M | -8.53M | -6.41M | -6.42M | -5.64M | -7.44M | -6.39M | -6.48M | -9.03M | -9.02M | -6.66M |
| Net Interest Income | 0 | 210K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 631K | 499K | 1.23M | 243K | -450K | -425K | -21.31M | 0 | 0 |
| Interest Income | 0 | 210K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 631K | 612K | 1.42M | 525K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 113K | 191K | 282K | 450K | 425K | 21.31M | 0 | 0 |
| Other Income/Expense | 405K | 210K | 961K | 113K | 166K | 249K | 193K | 119K | -8K | -29K | -35K | -90K | -113K | -191K | -282K | -450K | -425K | -641K | -437K | -101K |
| Pretax Income | -5.41M | -5.26M | -6.47M | -24.46M | -9.74M | -9.22M | -12.09M | -9.75M | -11.03M | -8.41M | -8.56M | -6.5M | -6.54M | -5.83M | -7.72M | -6.84M | -6.9M | -9.67M | -9.46M | -6.66M |
| Pretax Margin % | - | - | - | - | -19478% | - | - | - | -78750% | -30028.57% | -19913.95% | -14132.61% | -17200% | -6013.4% | -7882.65% | -42737.5% | -4234.97% | -5933.13% | -67557.14% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.41M | -5.26M | -6.47M | -24.46M | -9.74M | -9.22M | -12.09M | -9.75M | -11.03M | -8.41M | -8.56M | -6.5M | -6.54M | -5.83M | -7.72M | -6.84M | -6.9M | -9.67M | -9.46M | -6.66M |
| Net Margin % | - | - | - | - | -19478% | - | - | - | -78750% | -30028.57% | -19913.95% | -14132.61% | -17200% | -6013.4% | -7882.65% | -42737.5% | -4234.97% | -5933.13% | -67557.14% | - |
| Net Income Growth % | 44.48% | 42.89% | 46.48% | -150.95% | 11.66% | -9.63% | -41.22% | -49.92% | -68.68% | -44.15% | -10.85% | 4.93% | 5.32% | 39.69% | 18.32% | -2.75% | -51.51% | -201.84% | -100.51% | -215.73% |
| Net Income (Continuing) | -5.41M | -5.26M | -6.47M | -24.46M | -9.74M | -9.22M | -12.09M | -9.75M | -11.03M | -8.41M | -8.56M | -6.5M | -6.54M | -5.83M | -7.72M | -6.84M | -6.9M | -9.67M | -9.46M | -6.66M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.20 | -0.20 | -0.24 | -1.05 | -0.43 | -0.41 | -0.60 | -0.50 | -0.61 | -0.47 | -0.48 | -0.36 | -0.37 | -0.34 | -0.45 | -0.41 | -0.41 | -0.56 | -0.55 | -0.44 |
| EPS Growth % | 53.49% | 51.22% | 60% | -110% | 29.51% | 12.77% | -25% | -38.89% | -64.86% | -38.24% | -6.67% | 12.2% | 9.76% | 39.29% | 18.18% | 6.82% | -28.13% | -124% | -52.78% | -120% |
| EPS (Basic) | -0.20 | -0.20 | -0.24 | -1.05 | -0.43 | -0.41 | -0.60 | -0.50 | -0.61 | -0.47 | -0.48 | -0.36 | -0.37 | -0.34 | -0.45 | -0.41 | -0.41 | -0.56 | -0.55 | -0.44 |
| Diluted Shares Outstanding | 26.59M | 26.59M | 26.59M | 23.3M | 22.5M | 22.28M | 20.19M | 19.31M | 18.03M | 17.95M | 18.01M | 17.95M | 17.95M | 17.93M | 17.95M | 17.95M | 17.87M | 17.33M | 17.33M | 14.97M |
| Basic Shares Outstanding | 26.59M | 26.59M | 26.59M | 23.3M | 22.5M | 22.28M | 20.19M | 19.31M | 18.03M | 17.95M | 18.01M | 17.95M | 17.95M | 17.93M | 17.95M | 17.95M | 17.87M | 17.33M | 17.33M | 14.97M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |